Oct 30 2020

Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 – Book Publishing Industry Today – EIN Presswire

Trusted News Since 1995

A service for publishing professionals
·
Sunday, November 1, 2020

·
529,739,055
Articles

·
3+ Million Readers